Sec Form 4 Filing - Barra Ornella @ Walgreens Boots Alliance, Inc. - 2018-07-16

FORM 4 Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL OMB Number: 3235-0287 Expires: November 30, 2011 Estimated average burden hours per response... 0.5

1. Name and Address of Reporting Person Barra Ornella 2. Issuer Name and Ticker or Trading Symbol Walgreens Boots Alliance, Inc. [ WBA] 5. Relationship of Reporting Person(s) to Issuer (Check all applicable) _____ Director _____ 10% Owner X __ Officer (give title below) _____ Other (specify below) Co-Chief Operating Officer (Last) (First) (Middle) 24 BOULEVARD DU TENAO 3. Date of Earliest Transaction (MM/DD/YY) 07/16/2018 (Street) MONTE CARLO, O998000 4. If Amendment, Date Original Filed (MM/DD/YY) 6. Individual or Joint/Group Filing (Check Applicable Line) __ X __ Form filed by One Reporting Person _____ Form filed by More than One Reporting Person (City) (State) (Zip)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned 1.Title of Security (Instr. 3) 2. Transaction Date (MM/DD/YY) 2A. Deemed Execution Date, if any (MM/DD/YY) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4) Code V Amount (A) or (D) Price Common Stock, par value $0.01 per share 07/16/2018 S 1,697,438 ( 1 ) D $ 63.92 0 D Common Stock, par value $0.01 per share 07/16/2018 P 1,700,000 ( 2 ) A $ 65.15 1,700,000 I By OLB ( 3 )

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned ( e.g. , puts, calls, warrants, options, convertible securities) 1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (MM/DD/YY) 3A. Deemed Execution Date, if any (MM/DD/YY) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4, and 5) 6. Date Exercisable and Expiration Date (MM/DD/YY) 7. Title and Amount of Underlying Securities (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of Derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4) Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares Employee Stock Option (right to buy) $ 84.68 ( 4 ) 11/01/2025 Common Stock 84,466 84,466 D Employee Stock Option (right to buy) $ 82.46 11/01/2019( 5 ) 11/01/2026 Common Stock 140,844 140,844 D Employee Stock Option (right to buy) $ 67.01 ( 6 ) 11/01/2027 Common Stock 161,506 161,506 D

Reporting Owners Reporting Owner Name / Address Relationships Director 10% Owner Officer Other Barra Ornella 24 BOULEVARD DU TENAO MONTE CARLO, O998000 Co-Chief Operating Officer Signatures Benjamin S.J. Burman, attorney-in-fact 07/17/2018 Signature of Reporting Person Date

Explanation of Responses:

( 1 )On July 16, 2018, the Reporting Person sold 1,697,438 shares of Common Stock for cash to Alliance Sante Participations S.A. in a private off-market and offshore transaction pursuant to a Share Purchase Agreement, dated July 16, 2018, for a purchase price of $63.92 per share (being the price equal to the 5-day volume weighted average price per share of Common Stock on the NASDAQ for the 5-trading day period ending on (and including) July 13, 2018, the last trading day immediately prior to the entry into the Share Purchase Agreement). ( 2 )On July 16, 2018, OLB Holdings Ltd. purchased 1,700,000 shares of Common Stock in a block trade from UBS Securities LLC, acting as seller and as a principal, for a purchase price of $65.15 per share. ( 3 )Shares of Common Stock are held of record by a corporation, OLB Holdings Ltd. ('OLB') which is 100% owned by the Reporting Person. ( 4 )The option vested with respect to 28,127 shares on November 1, 2016 and with respect to a further 28,127 shares on November 1, 2017, and vests with respect to 28,212 shares on November 1, 2018, subject to acceleration or forfeiture in certain circumstances in accordance with the terms and conditions of the Walgreens Boots Alliance, Inc. 2013 Omnibus Incentive Plan, as amended (together with the related agreement thereunder). ( 5 )The option vests on November 1, 2019, subject to acceleration or forfeiture in certain circumstances in accordance with the terms and conditions of the Walgreens Boots Alliance, Inc. 2013 Omnibus Incentive Plan, as amended (together with the related agreement thereunder). ( 6 )The option vests with respect to 53,781 shares on November 1, 2018, with respect to 53,781 shares on November 1, 2019 and with respect to 53,944 shares on November 1, 2020, subject to acceleration or forfeiture in certain circumstances in accordance with the terms and conditions of the Walgreens Boots Alliance, Inc. 2013 Omnibus Incentive Plan, as amended (together with the related agreement thereunder).

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.

* If the form is filed by more than one reporting person, see Instruction 4(b)(v).

** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.